Tonix Pharmaceuticals Holding Corp.
NASDAQ:TNXP
0.39 (USD) • At close December 24, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Tonix Pharmaceuticals Holding Corp. |
Symbool | TNXP |
Munteenheid | USD |
Prijs | 0.385 |
Beurswaarde | 72,010,258 |
Dividendpercentage | 0% |
52-weken bereik | 0.12 - 14.08 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Seth Lederman M.D. |
Website | https://www.tonixpharma.com |
An error occurred while fetching data.
Over Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company's immunology portfolio includes biologics to address
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)